Patients can benefit from TRB’s long‑standing experience in ophthalmic surgery, with solutions developed to support eye care professionals in reducing complications during and after cataract surgery and other anterior‑segment procedures.²
This expertise is grounded in the use of hyaluronic acid–based technologies, designed to meet the specific requirements of intraocular surgery.

TRB has developed a hyaluronic acid solution combined with mannitol for use as an ophthalmic viscosurgical device (OVD) during anterior‑segment eye surgery, including cataract surgery, intraocular lens implantation, corneal transplantation and glaucoma filtering surgery.²

Hyaluronic acid plays a central role in ophthalmic surgery thanks to its viscoelastic properties, which allow it to:

• Create and maintain intraocular space
• Support chamber depth
• Facilitate intraocular lens implantation

During surgery, this contributes to tissue protection, structural stability and optimal visibility.² The addition of mannitol helps to reduce oxidative stress and endothelial damage, supporting the preservation of tissue integrity throughout the surgical procedure.^2-3

The combination of hyaluronic acid and mannitol is designed to support:

• Protection of ocular tissues, including the corneal endothelium
• Maintenance of good visibility during surgery
• Smooth handling characteristics during intraocular procedures

Easy handling during surgery contributes to efficient, safe procedures and supports optimal surgical outcomes for patients.²